Back
radioligand therapy for prostate cancerOrganizationsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Projects attributed to UNIVERSITY OF CALIFORNIA, SAN FRANCISCO within this analysis sample.

In This Analysis
Projects
11
NIH Funding
$12.5M
Projects(11)
ProjectPICategoryFunding
FLAVELL, ROBERT RICHARDTherapeutics$2.0M
EVANS, MICHAEL JOHNTherapeutics$1.8M
VIGNERON, DANIEL BTherapeutics$1.3M
VIGNERON, DANIEL BTherapeutics$1.3M
BARCELLOS-HOFF, MARY HELENTherapeutics$1.3M
VANBROCKLIN, HENRY F.Diagnostics$1.2M
HOPE, THOMAS A.Therapeutics$1.1M
FONG, LAWRENCEInfrastructure$982K
FENG, FELIX YI-CHUNG (contact)Therapeutics$626K
EVANS, MICHAEL JOHNTherapeutics$575K
BIDKAR, ANIL PARSRAMTraining$372K
See UNIVERSITY OF CALIFORNIA, SAN FRANCISCO’s full platform profile
Cross-source view across the entire granted.bio dataset — projects, trials, patents, and publications spanning every topic, not just this analysis.